يحاول ذهب - حر
How India's Diabetes Crisis is Driving Med Devices Market
December 2025
|Bio Spectrum
A growing diabetic population in India is a blessing for the care devices market. Both Indian and global diabetes care devices have taken this growing demand for various devices, kits as an opportunity to expand their market share. But the scope in rural areas seems a bit challenging for various companies due to less awareness about the disease, affordability etc. Let's look at this growing diabetes care devices market.
With diabetes seeing an uptick and India being the Diabetes Capital of the World, the diabetes care devices market is experiencing robust growth. A GlobalData analysis reveals that India accounted for around 20 per cent of the Asia-Pacific (APAC) diabetes care devices market in 2024, driven by a confluence of factors, including a rapidly escalating diabetic population, increased diagnosis, rising disposable incomes, and the adoption of advanced diabetes management technologies.
According to Frost & Sullivan analysis, the Indian diabetes care devices market is currently estimated at $4.8 billion and will reach $7.7 billion in 2030 with a projected compounded annual growth rate (CAGR) of approximately 9 per cent for the projected period of 2026-2030.
The digital health platforms segment reflects its high growth potential and encompasses a range of interconnected technologies, services, and applications. Its key components are mobile health (mHealth) apps for medication nudges and diet and exercise logs, teleconsultation and remote patient monitoring packages, predictive analytics for personalised medicine, and patient data management software. The segment will experience rapid adoption, driven by India's high smartphone penetration, the government's initiatives like the India AI mission, and growing Internet connectivity.
Key growth drivers
Rising disease prevalence, increased health awareness, strategic partnerships in the private sector, technological advancements, insurance and corporate wellness inclusion, E-commerce and telehealth penetration. According to Frost and Sullivan, government initiatives such as Ayushman Bharat undertake population-based screening for non-communicable diseases like diabetes in individuals over 30 years of age by trained frontline workers, have helped the sector to flourish.
هذه القصة من طبعة December 2025 من Bio Spectrum.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Bio Spectrum
Bio Spectrum
Building Breakthrough Medical Devices
Dr Ria Khurana founded RNT Health Insights, a Chandigarh-based healthtech startup specialising in Al-assisted diagnostic solutions for the accurate detection of pathologies during endoscopic procedures, in 2022 along with Dr Tanmaya Gulati.
2 mins
January 2026
Bio Spectrum
Bridging classical epidemiology with modern science
A physician scientist with a MBBS from Lady Hardinge Medical College, (University of Delhi), a post-graduation in Paediatrics and a PhD from All India Institute of Medical Sciences (AIIMS), New Delhi, Prof.Shinjini Bhatnagar served as Professor of Eminence at Translational Health Science and Technology Institute (THSTI) until February 2023 and was subsequently appointed Distinguished Professor at THSTI until May 2025.
2 mins
January 2026
Bio Spectrum
"AI, Automation & Analytics: A new era of modern microbiology testing!"
Pharmaceutical manufacturing is undergoing a paradigm shift.
4 mins
January 2026
Bio Spectrum
The CRISPR Moment
CRISPR (clustered regularly interspaced short palindromic repeats) technology is ushering in a new era of gene and cell therapy, offering more precision and potential for treating genetic disorders, cancer, and infectious diseases.
2 mins
January 2026
Bio Spectrum
Leveraging Microfluidic Technology for mRNA-LNP Manufacturing
Over the past five years, messenger RNA (mRNA) therapeutics have evolved from experimental concepts into lifesaving medicines.
2 mins
January 2026
Bio Spectrum
Demonstrating India's Vaccine Capabilities
Havisure is India's first and only indigenously developed Hepatitis A vaccine, to address one of the country's most persistent public health challengeswidespread Hepatitis A infections caused by inadequate sanitation and contaminated food and water.
2 mins
January 2026
Bio Spectrum
Inspiring Future Generations
A PhD in molecular biology from the University of Cambridge, UK, Prof. Gaiti Hasan is a Distinguished Fellow at the National Centre for Biological Sciences (NCBS), Bengaluru.
2 mins
January 2026
Bio Spectrum
A Landmark for India's Antibiotic Innovation
After three decades of research and hard work, India has led the way with the creation of Nafithromycin, the country's first indigenous antibiotic.
2 mins
January 2026
Bio Spectrum
"Future vaccine innovation will be integration of R&D, regulatory support and manufacturing”
TechInvention Lifecare Limited, a vaccine focused biotechnology company headquartered in Mumbai, is recognised for its innovative contributions to global healthcare.
4 mins
January 2026
Bio Spectrum
Telangana: Building India's Most Credible Life Sciences Ecosystem
Telangana's recognition as BioSpectrum India's Best Performing State in Life Sciences 2025 is a timely validation of the direction the state has taken in recent years-one anchored in execution, responsiveness, and a clear understanding of where global life sciences value chains are headed.
4 mins
January 2026
Listen
Translate
Change font size

